PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis

FEBS Letters

Volumn 586, Issue 24, 2012, Pages 4296-4302

  Kim, Han A ^a   Kim, Kyoung Jin ^a   Seo, Kook Heon ^b   Lee, Hern Ku ^c   Im, Suhn Young ^a  

^a Chonnam National University   (South Korea)

^b Jeollanamdo Biopharmaceutical Research Center   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

MAPK; Platelet activating factor; PTEN; Tumor metastasis

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; THROMBOCYTE ACTIVATING FACTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; EXPERIMENTAL NEOPLASM; EXPERIMENTAL PULMONARY TUMOR METASTASIS; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS CARRIER;

ANDROSTADIENES; ANIMALS; ANTHRACENES; BUTADIENES; CELL LINE; HUMANS; IMIDAZOLES; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PLATELET ACTIVATING FACTOR; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; PYRIDINES;

ADENOVIRIDAE;

EID: 84870574320     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.10.034     Document Type: Article

References (41)

1. B. Farron, and B.M. Evers Inflammation and the development of pancreatic cancer Surg. Oncol. 10 2002 153 169
2. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
3. J. Marx Inflammation and cancer. The link grows stronger Science 306 2004 966 968
4. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
5. J. Condeelis, and J.W. ollard Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2006 263 266
6. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev. Cancer 2 2002 161 174
7. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat. Rev. Immunol. 5 2005 749 759
8. A.I. Fukuda, and K.F. Breuel Effect of platelet-activating factor on embryonic development and implantation in the mouse Hum. Reprod. 11 1996 2746 2749
9. S.D. Shukla Platelet-activating factor receptor and signal transduction mechanisms FASEB J. 6 1992 2296 2301
10. T.M. Buttke, and P.A. Sandstrom Redox regulation of programmed cell death in lymphocytes Free Radical Res. 22 1995 389 397
11. P. Braquet, L. Touqui, T.Y. Shen, and B.B. Vargaftig Perspectives in platelet-activating factor research Pharmacol. Rev. 39 1987 97 145
12. S.Y. Im, H.M. Ko, J.W. Kim, H.K. Lee, T.Y. Ha, H.B. Lee, S.J. Oh, S. Bai, K.C. Chung, Y.B. Lee, H.S. Kang, and S.B. Chun Augmentation of tumor metastasis by platelet-activating factor Cancer Res. 56 1996 2662 2665
13. S.Y. Im, S.J. Han, H.M. Ko, J.H. Choi, S.B. Chun, D.G. Lee, T.Y. Ha, and H.K. Lee Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression Eur. J. Immunol. 27 1997 2800 2804
14. S.J. Han, J.H. Choi, H.M. Ko, H.W. Yang, I.W. Choi, H.K. Lee, O.H. Lee, and S.Y. Im Glucocorticoids prevent NF-kappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide Eur. J. Immunol. 29 1999 1334 1341
15. J.H. Choi, H.M. Ko, J.W. Kim, H.K. Lee, S.S. Han, S.B. Chun, and S.Y. Im Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans J. Immunol. 166 2001 5139 5144
16. H.M. Ko, K.H. Seo, S.J. Han, K.Y. Ahn, I.H. Choi, G.Y. Koh, H.K. Lee, M.S. Ra, and S.Y. Im Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis Cancer Res. 62 2002 1809 1814
17. K.H. Seo, H.M. Ko, J.H. Choi, H.H. Jung, Y.H. Chun, I.W. Choi, H.K. Lee, and S.Y. Im Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis Eur. J. Immunol. 34 2004 2129 2137
18. H.M. Ko, J.H. Kang, B. Jung, H.A. Kim, S.J. Park, K.J. Kim, Y.R. Kang, H.K. Lee, and S.Y. Im Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis Int. J. Cancer 120 2007 1277 1283
19. H.M. Ko, Y.M. Park, B. Jung, H.A. Kim, J.H. Choi, S.J. Park, H.K. Lee, and S.Y. Im Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis FEBS Lett. 579 2005 2369 2375
20. K.H. Seo, H.M. Ko, H.A. Kim, J.H. Choi, S.J. Park, K.J. Kim, H.K. Lee, and S.Y. Im Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation Cancer Res. 66 2006 4681 4686
21. M.P. Myers, J.P. Stolarov, C. Eng, J. Li, S.I. Wang, M.H. Wigler, R. Parsons, and N.K. Tonks P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase Proc. Natl. Acad. Sci. USA 94 1997 9052 9057
22. L. Simpson, and R. Parsons PTEN: life as a tumor suppressor Exp. Cell Res. 264 2001 29 41
23. B.H. Jiang, and L.Z. Liu PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochim. Biophys. Acta 1784 2008 150 158
24. H. Suzuki, D. Freije, D.R. Nusskern, K. Okami, P. Cairns, D. Sidransky, W.B. Isaacs, and G.S. Bova Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues Cancer Res. 58 1998 204 209
25. M. Hahn, I. Wieland, O.N. Koufaki, H. Görgens, S.B. Sobottka, G. Schackert, and H.K. Schackert Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases Clin. Cancer Res. 5 1999 2431 2437
26. M. Tamura, J. Gu, K. Matsumoto, S. Aota, R. Parsons, and K.M. Yamada Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Science 280 1998 1614 1617
27. M.A. Davies, S.J. Kim, N.U. Parikh, Z. Dong, C.D. Bucana, and G.E. Gallick Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells Clin. Cancer Res. 8 2002 1904 1914
28. P.H. Hwang, H.K. Yi, D.S. Kim, S.Y. Nam, J.S. Kim, and D.Y. Lee Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene Cancer Lett. 172 2001 83 91
29. N.I. Kang, H.Y. Yoon, H.A. Kim, K.J. Kim, M.K. Han, Y.R. Lee, P.H. Hwang, B.Y. Soh, S.J. Shin, S.Y. Im, and H.K. Lee Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock J. Immunol. 186 2011 6625 6632
30. T. Maehama, and J.E. Dixon The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate J. Biol. Chem. 273 1998 13375 13378
31. J. Gu, M. Tamura, and K.M. Yamada Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways J. Cell Biol. 143 1998 1375 1383
32. A. Agarwal, K. Das, N. Lerner, S. Sathe, M. Cicek, G. Casey, and N. Sizemore The AKT/IkappaB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappaB and beta-catenin Oncogene 24 2005 1021 1031
33. G.Z. Cheng, S. Park, S. Shu, L. He, W. Kong, W. Zhang, Z. Yuan, L.H. Wang, and J.Q. Cheng Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery Curr. Cancer Drug Targets 8 2008 2 6
34. B. Stiles, V. Gilman, N. Khanzenzon, R. Lesche, A. Li, R. Qiao, X. Liu, and H. Wu Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis Mol. Cell. Biol. 22 2002 3842 3851
35. H.A. Kim, K.J. Kim, S.Y. Yoon, H.K. Lee, and S.Y. Im Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis Eur. J. Cancer 48 2012 1730 1738
36. I. Vivanco, N. Palaskas, C. Tran, S.P. Finn, G. Getz, N.J. Kennedy, J. Jiao, J. Rose, W. Xie, M. Loda, T. Golub, I.K. Mellinghoff, R.J. Davis, H. Wu, and C.L. Sawyers Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN Cancer Cell 11 2007 555 569
37. X.M. Cai, B.B. Tao, L.Y. Wang, Y.L. Liang, J.W. Jin, Y. Yang, Y.L. Hu, and X.L. Zha Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression Int. J. Cancer 117 2005 905 912
38. N. Dey, H.E. Crosswell, P. De, R. Parsons, Q. Peng, J.D. Su, and D.L. Durden The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration Cancer Res. 68 2008 1862 1871
39. F. Vazquez, S. Ramaswamy, N. Nakamura, and W.R. Sellers Phosphorylation of the PTEN tail regulates protein stability and function Mol. Cell. Biol. 20 2000 5010 5018
40. S.J. Miller, D.Y. Lou, D.C. Seldin, W.S. Lane, and B.G. Neel Direct identification of PTEN phosphorylation sites FEBS Lett. 528 2002 145 153
41. J. Torres, and R. Pulido The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation J. Biol. Chem. 276 2001 993 998